Transition metal diamine complexes with antimicrobial activity against Staphylococcus aureus and methicillin-resistant S. aureus (MRSA)

被引:18
|
作者
Karpin, G. W. [1 ,2 ]
Morris, D. M. [1 ,2 ]
Ngo, M. T. [1 ,2 ]
Merola, J. S. [1 ,2 ]
Falkinham, J. O., III [1 ,3 ]
机构
[1] Virginia Tech Ctr Drug Discovery, Blacksburg, VA 24061 USA
[2] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA
[3] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA
关键词
ORGANOMETALLIC COMPOUNDS; INFECTION; TRENDS;
D O I
10.1039/c5md00228a
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pentaalkylcyclopentadienyl (Cp*(R)) iridium (Ir) and cobalt (Co) 1,2-diamine complexes were synthesized. Susceptibility of Staphylococcus aureus and recent patient methicillin-resistant S. aureus (MRSA) isolates to the transition metal-diamine complexes were measured by broth microdilution and reported as the MIC and MBC. Hemolytic activities of the transition metal-complexes as well as toxicity toward Vero cells were also measured. The transition metal complex of Cp*Ir-R with cis-1,2-diaminocyclohexane, had strong antibiotic activity against S. aureus and MRSA (MIC = 4 mu g mL(-1), MBC = 8 mu g mL(-1)) strains and killed 99% of S. aureus cells in 6 hours. Stronger antibiotic activity was associated with the presence of octyl linked to the cyclopentadienyl group and cyclohexane as the diamine backbone. Activity was greatly diminished by trior tetramethylation of the nitrogen of the diamine. A cyclopentadienylcobalt complex of cis-1,2-diaminocyclohexane also showed significant anti-microbial activity against both S. aureus and MRSA strains. The absence of hemolytic activity, Vero cell cytotoxicity and the significant anti-microbial activity of several members of the family of compounds reported suggest this is an area worth further development.
引用
收藏
页码:1471 / 1478
页数:8
相关论文
共 50 条
  • [41] In vitro activity of the antimicrobial peptide AP7121 against the human methicillin-resistant biofilm producers Staphylococcus aureus and Staphylococcus epidermidis
    Delpech, Gaston
    Ceci, Monica
    Lissarrague, Sabina
    Garcia Allende, Leonardo
    Baldaccini, Beatriz
    Sparo, Monica
    BIOFOULING, 2020, 36 (03) : 266 - 275
  • [42] Protective Effect of Methicillin-Susceptible Staphylococcus aureus Carriage against Methicillin-Resistant S. aureus Acquisition in Nursing Homes: A Prospective Cross-Sectional Study
    Datta, Rupak
    Quan, Victor
    Kim, Diane
    Peterson, Ellena M.
    Reynolds, Courtney
    Meyers, Hildy
    Cheung, Michele
    Huang, Susan S.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (10) : 1257 - 1262
  • [43] Antibacterial and Antibiofilm Activity of Zinc Oxide Quantum Dots against Methicillin-resistant Staphylococcus aureus
    Abbas, Zahraa Neamah
    Abdullah, Hanaa N.
    Hallaji, Zahra
    Ranjbar, Bijan
    PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION, 2024,
  • [44] Methicillin-Resistant Staphylococcus aureus Nasal Swab Is Insufficient to Withhold Empiric Methicillin-Resistant Staphylococcus aureus Pneumonia Coverage in a Trauma Population
    Harrell, Kevin N.
    Koestner, Tyler
    Lloyd, Jacob
    Carter, Breanna L.
    Hunt, Darren
    Dart, Benjamin
    Maxwell, Robert
    JOURNAL OF SURGICAL RESEARCH, 2023, 285 : 45 - 50
  • [45] Prevalence of Staphylococcus aureus and methicillin-resistant S aureus on environmental surfaces in Ohio nursing homes
    Cheatham, Shanice
    Thapaliya, Dipendra
    Taha, Mohammed
    Milliken, Katherine
    Dalman, Mark R.
    Kadariya, Jhalka
    Grenier, Dylan
    Smith, Tara C.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2019, 47 (12) : 1415 - 1419
  • [46] Evaluation of Antibiotics Active against Methicillin-Resistant Staphylococcus aureus Based on Activity in an Established Biofilm
    Meeker, Daniel G.
    Beenken, Karen E.
    Mills, Weston B.
    Loughran, Allister J.
    Spencer, Horace J.
    Lynn, William B.
    Smeltzer, Mark S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 5688 - 5694
  • [47] Methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis
    Giron, Rosa M.
    Buendia, Buenaventura
    Pinedo, Celia
    Casanova, Alvaro
    Hoyos, Nieves
    Ancochea, Julio
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2009, 27 (02): : 85 - 88
  • [48] Prevention and control of methicillin-resistant Staphylococcus aureus infections
    Farr, BM
    CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (04) : 317 - 322
  • [49] Usefulness of Weekly Methicillin-Resistant Staphylococcus aureus Screening
    Rymzhanova, Raouchan
    Thouverez, Michelle
    Talon, Daniel
    Bertrand, Xavier
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (11) : 1113 - 1115
  • [50] Update on methicillin-resistant Staphylococcus aureus in cystic fibrosis
    Dasenbrook, Elliott C.
    CURRENT OPINION IN PULMONARY MEDICINE, 2011, 17 (06) : 437 - 441